Dube Michael P
VP, Chief Accounting Officer
CIK: 2019493
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jan 5, 2026 | Intellia Therapeutics, Inc. (NTLA) | S | 2,989 | $9.21 | $27,528.69 | View Details Filing |
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jan 5, 2026 | Intellia Therapeutics, Inc. (NTLA) | S | 2,989 | $9.21 | $27,528.69 | View Details Filing |